For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Take a look at our BETA site and see what we’ve done so far.
Search and browse selected products
Purchase these through your usual distributor
Your guide to EMT markers in cancer.
To help you quickly select the right tools to study EMT, we've compiled the most common EMT markers and recommended reliable antibodies for these markers.
These changes in epithelial and mesenchymal cell marker expression lead to a reduction in adhesion between the transitioning cell and adjacent epithelial cells and an increase in the secretion of enzymes that degrade the extracellular matrix.1 Collectively, this results in epithelial cells losing apical-basal cell polarity, reorganizing their cytoskeleton, and reprogramming gene expression, which allows the development of an invasive phenotype in cancer metastasis.2
Decreased E-cadherin expression is a fundamental event in EMT and cancer metastasis and has emerged as a molecular hallmark of carcinoma EMT.3
The loss of E-cadherin is typically associated with a gain of expression of the mesenchymal marker, N-cadherin, in many cancer types. It is thought to be necessary for tumor cells to gain invasive properties.4
We recommend Anti-N Cadherin antibody (ab18203)
Image (above): Immunohistochemistry (formalin/PFA-fixed paraffin-embedded sections) of human liver cancer tissue stained with Anti-N Cadherin antibody (ab18203).
The change in the epithelial and mesenchymal gene expression that occurs during EMT is regulated by multiple transcription factor families, including SNAI1/Snail, ZEB1/ZEB2, and basic helix-loop-helix transcription factors (bHLH).2
We recommend Anti-SNAIL + SLUG antibody (ab180714).
Couldn't find what you were looking for?